FDA OKs Bioengineered Vessel to Reduce Limb Amputations After Vascular Trauma
(MedPage Today) -- The FDA on Friday approved acellular tissue engineered vessel (Symvess), an off-the-shelf product for treating vascular trauma in the extremities of adults.
The one-time, single-use therapy -- the first of its kind -- is...
The one-time, single-use therapy -- the first of its kind -- is...